Psychosocial functioning and cocaine use during treatment: Strength of relationship depends on type of urine-testing method

Drug and Alcohol Dependence

Volumn 91, Issue 2-3, 2007, Pages 169-177

  Ghitza, Udi E ^a   Epstein, David H ^a   Preston, Kenzie L ^a  

^a Intramural Research Program   (United States)

Author keywords

Abstinence reinforcement; Methadone maintenance; Psychosocial function; Substance dependence; Treatment; Urinalysis

Indexed keywords

METHADONE;

ABSTINENCE; ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG DEPENDENCE TREATMENT; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL ADAPTATION; SOCIAL PSYCHOLOGY; URINALYSIS;

ADULT; COCAINE; COCAINE-RELATED DISORDERS; DEPRESSION; HEROIN DEPENDENCE; HUMANS; MONITORING, PHYSIOLOGIC; PATIENT DROPOUTS; REINFORCEMENT (PSYCHOLOGY); SOCIAL ADJUSTMENT; SOCIAL SUPPORT;

EID: 35048898287     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.05.018     Document Type: Article

References (44)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (1994), American Psychiatric Association, Washington, DC
2. Beck A.T., and Steer R.A. Beck Depression Inventory Manual (1987), The Psychological Corporation/Harcourt Brace Jovanovich, Inc., New York
3. Belendiuk, K.A., Epstein, D.H., Schmittner, J.P., Preston, K.L., 2006. HIV risk taking behaviors in hepatitis C-positive and negative polydrug abusers in drug treatment. In: The College on Problems of Drug Dependence Abstracts.
4. Brodaty H., Peters K., Boyce P., Hickie I., Parker G.I., Mitchell P., and Wilhelm I.K. Age and depression. J. Affect. Disord. 23 (1991) 137-149
5. Delucchi K.L., Batki S.L., Moon J., Jacob III P., and Jones R.T. Urine toxicology samples in cocaine treatment trials: how many need to be tested?. J. Addict. Dis. 21 (2002) 17-26
6. Delucchi K.L., Jones R.T., and Batki S.L. Measurement properties of quantitative urine benzoylecgonine in clinical trials research. Addiction 92 (1997) 297-302
7. Dumville J.C., Hahn S., Miles J.N., and Torgerson D.J. The use of unequal randomisation ratios in clinical trials: a review. Contemp. Clin. Trials 27 (2006) 1-12
8. Epstein, D.H., Schmittner, J., Schroeder, J.R., Preston, K.L., 2003. Promoting simultaneous abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. In: The College on Problems of Drug Dependence Abstracts.
9. Garber J., Kriss M.R., Koch M., and Lindholm L. Recurrent depression in adolescents: a follow-up study. J. Am. Acad. Child Adolesc. Psychiatry 27 (1988) 49-54
10. Goldman H.H., Skodol A.E., and Lave T.R. Revising axis V for DSM-IV: a review of measures of social functioning. Am. J. Psychiatry 149 (1992) 1148-1156
11. Hedeker D., and Gibbons R.D. Application of random-effects pattern-mixture models for missing data in longitudinal studies. Psychol. Methods 2 (1997) 64-78
12. Higgins S.T., Delaney D.D., Budney A.J., Bickel W.K., Hughes J.R., Foerg F., and Fenwick J.W. A behavioral approach to achieving initial cocaine abstinence. Am. J. Psychiatry 148 (1991) 1218-1224
13. Hudson C.R., Kirby K.C., Firely M.L., Festinger D.S., and Marlowe D.B. Social adjustment of family members and significant others (FSOs) of drug users. J. Subst. Abuse Treat. 23 (2002) 171-181
14. Jufer R., Walsh S.L., Cone E.J., and Sampson-Cone A. Effect of repeated cocaine administration on detection times in oral fluid and urine. J. Anal. Toxicol. 30 (2006) 458-462
15. Jufer R.A., Wstadik A., Walsh S.L., Levine B.S., and Cone E.J. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. J. Anal. Toxicol. 24 (2000) 467-477
16. Kampman K.M., Pettinati H.M., Volpicelli J.R., Oslin D.M., Lipkin C., Sparkman T., and O'Brien C.P. Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcohol. Am. J. Addict. 13 (2004) 74-82
17. Kosten T.R., Rounsaville B.J., and Kleber H.D. Relationship of depression to psychosocial stressors in heroin addicts. J. Nerv. Ment. Dis. 171 (1983) 97-104
18. Lasa L., Ayuso-Mateos J.L., Vazquez-Barquero J.L., Diez-Manrique F.J., and Dowrick C.F. The use of the Beck Depression Inventory to screen for depression in the general population: a preliminary analysis. J. Affect. Disord. 57 (2000) 261-265
19. Li S.H., Chiang C.N., Tai B.C., Marschke C.K., and Hawks R.L. Quantitative versus qualitative urinalysis for benzoylecgonine in clinical trials for the assessment of cocaine use. Psychopharmacol. Bull. 31 (1995) 671-679
20. Livingston M.G., Brooks D.N., and Bond M.P. Patient outcome in the year following severe head injury and relatives' psychiatric and social functioning. J. Neurol. Neurosurg. Psychiatry 48 (1985) 876-881
21. McLellan A.T., Luborsky L., Cacciola J., Griffith J., Evans F., Barr H.L., and O'Brien C.P. New data from the Addiction Severity Index. Reliability and validity in three centers. J. Nerv. Ment. Dis. 173 (1985) 412-423
22. Miele G.M., Carpenter K.M., Smith Cockerham M., Trautman K.D., Blaine J., and Hasin D.S. Substance Dependence Severity Scale (SDSS): reliability and validity of a clinician-administered interview for DSM-IV substance use disorders. Drug Alcohol Depend. 59 (2000) 63-75
23. Nich C., and Carroll K. Now you see it, now you don't: a comparison of traditional versus random-effects regression models in the analysis of longitudinal follow-up data from a clinical trial. J. Consult. Clin. Psychol. 65 (1997) 252-261
24. National Institute on Drug Abuse, 2006. Epidemiologic Trends in Drug Abuse: Advance Report, June 2006. U.S. Department of Health and Human Services, National Institutes of Health, Bethesda, MD.
25. Petry N.M., and Martin B. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J. Consult. Clin. Psychol. 70 (2002) 398-405
26. Preston K.L., Silverman K., Higgins S.T., Brooner R.K., Montoya I., Schuster C.R., and Cone E.J. Cocaine use early in treatment predicts outcome in a behavioral treatment program. J. Consult. Clin. Psychol. 66 (1998) 691-696
27. Preston K.L., Silverman K., Schuster C.R., and Cone E.J. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction 92 (1997) 717-727
28. Preston K.L., Silverman K., Schuster C.R., and Cone E.J. Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies. NIDA Res. Monogr. 167 (1997) 130-145
29. Preston K.L., Silverman K., Schuster C.R., and Cone E.J. Use of quantitative urinalysis in monitoring cocaine use. NIDA Res. Monogr. 175 (1997) 253-264
30. Preston K.L., Umbricht A., and Epstein D.H. Abstinence reinforcement maintenance contingency and one-year follow-up. Drug Alcohol Depend. 67 (2002) 125-137
31. Robins L.N., Cottler L.B., Bucholz K.K., and Compton III W.M. The Diagnostic Interview Schedule, version IV (1995), Washington University, St. Louis, MO
32. Rounsaville B.J., Kosten T.R., and Weissman M.M. Prognostic significance of psychopathology in treated opiate addicts: a 2.5-year follow-up study. Arch. Gen. Psychiatry 43 (1986) 739-745
33. Rounsaville B.J. Treatment of cocaine dependence and depression. Biol. Psychiatry 56 (2004) 803-809
34. Schneider L.S., Zemansky M.F., Bender M., and Sloane R.B. Personality in recovered depressed elderly. Int. Psychogeriatr. 4 (1992) 177-185
35. Schroeder J.R., Gupman A.E., Epstein D.H., Umbricht A., and Preston K.L. Do noncontingent vouchers increase drug use?. Exp. Clin. Psychopharmacol. 11 (2003) 195-201
36. Silverman K., Wong C.J., Higgins S.T., Brooner R.K., Montoya I.D., Contoreggi C., Umbricht-Schneiter A., Schuster C.R., and Preston K.L. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend. 41 (1996) 157-165
37. Tai, B., 1997. Appendix I: Workshop summary-outcome measures and success criteria. In: NIDA Research Monograph 175, Medication Development for the Treatment of Cocaine Dependence: Issues in Clinical Efficacy Trials. National Institute on Drug Abuse, Rockville, MD, pp. 303-310.
38. Teichner G., Horner M.D., and Harvey R.T. Neuropsychological predictors of the attainment of treatment objectives in substance abuse patients. Int. J. Neurosci. 106 (2001) 253-263
39. Weissman M.M., and Bothwell S. Assessment of social adjustment by patient self-report. Arch. Gen. Psychiatry 33 (1976) 1111-1115
40. Weissman M.M., Prusoff B.A., Thompson W.D., Harding P.S., and Myers J.K. Social adjustment by self-report in a community sample and in psychiatric outpatients. J. Nerv. Ment. Dis. 166 (1978) 317-326
41. Weissman M.M., Sholomskas D., and John K. The assessment of social adjustment. An update. Arch. Gen. Psychiatry 38 (1981) 1250-1258
42. Weissman M.M., Olfson M., Gameroff M.J., Feder A., and Fuentes M. A comparison of three scales for assessing social functioning in primary care. Am. J. Psychiatry 158 (2001) 460-466
43. Woods S.W., Sholomskas D.E., Shear M.K., Gorman J.M., Barlow D.H., Goddard A.W., and Cohen J. Efficient allocation of patients to treatment cells in clinical trials with more than two treatment conditions. Am. J. Psychiatry 155 (1998) 1446-1448
44. Zachary, R., 1986. Shipley Institute of Living Scale. Revised Manual. Western Psychological Services, Los Angeles.